Sanjay Goel

8.4k total citations · 2 hit papers
269 papers, 5.2k citations indexed

About

Sanjay Goel is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sanjay Goel has authored 269 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Oncology, 80 papers in Molecular Biology and 61 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sanjay Goel's work include Colorectal Cancer Treatments and Studies (49 papers), Cancer Treatment and Pharmacology (35 papers) and Pancreatic and Hepatic Oncology Research (27 papers). Sanjay Goel is often cited by papers focused on Colorectal Cancer Treatments and Studies (49 papers), Cancer Treatment and Pharmacology (35 papers) and Pancreatic and Hepatic Oncology Research (27 papers). Sanjay Goel collaborates with scholars based in United States, India and Australia. Sanjay Goel's co-authors include Sridhar Mani, Radhashree Maitra, Christophe Le Tourneau, Édith Borcoman, John M. Mariadason, Umang Swami, Román Pérez-Soler, Mohammad H. Ghalib, Daniel T. Laskowitz and Ellen Bennett and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Sanjay Goel

247 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System

2020 521 citations Vikas Mehta, Sanjay Goel et al. Cancer Discovery profile →
Novel patterns of response under immunotherapy

2019 354 citations Sanjay Goel et al. profile →

Peers

Countries citing papers authored by Sanjay Goel

Since Specialization

Citations

This map shows the geographic impact of Sanjay Goel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjay Goel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjay Goel more than expected).

Fields of papers citing papers by Sanjay Goel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanjay Goel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjay Goel. The network helps show where Sanjay Goel may publish in the future.

Co-authorship network of co-authors of Sanjay Goel

This figure shows the co-authorship network connecting the top 25 collaborators of Sanjay Goel. A scholar is included among the top collaborators of Sanjay Goel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanjay Goel. Sanjay Goel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of Racial Disparities on Treatment of Early Triple Negative Breast Cancer Among American Indians/Alaska Natives and Non-Hispanic Whites 2025 ·Clinical Breast Cancer ·(unknown), Li Cao, (unknown), Abe E. Sahmoun, Sanjay Goel	1
2	Outcomes Among Racial and Ethnic Minority Patients With Advanced Cancers in Phase 1 Trials 2024 ·JAMA Network Open ·Sanjay Goel, Abdissa Negassa, Mohammad H. Ghalib, Imran Chaudhary, Kavita Desai, Umang Shah, Umang Swami, (unknown), Radhashree Maitra, Sridhar Mani	0
3	Targeting multiple receptor tyrosine kinases with sitravatinib: A Phase 1b study in advanced renal cell carcinoma and castrate-resistant prostate cancer 2024 ·Investigational New Drugs ·Shubham Pant, Byoung Chul Cho, Christos E. Kyriakopoulos, Alexander I. Spira, Nizar M. Tannir, Theresa L. Werner, Xiaohong Yan, Saskia Neuteboom, Richard C. Chao, Sanjay Goel	1
4	Uncovering actionable genetic alterations and immune predictive biomarkers for anal squamous cell carcinomas in the era of immunotherapy: PD-L1 and beyond. 2024 ·Journal of Clinical Oncology ·(unknown), Yasmine Baca, Joanne Xiu, Alex Farrell, George W. Sledge, Anwaar Saeed, Anthony F. Shields, (unknown), Sanjay Goel, Benjamin A. Weinberg, Emil Lou	1
5	Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic Targets 2024 ·JCO Precision Oncology ·Erik B. Faber, (unknown), (unknown), (unknown), Peter J. Hosein, Anthony F. Shields, Heinz‐Josef Lenz, (unknown), Sanjay Goel, Matthew J. Oberley, Giuseppe Malleo, Claudio Luchini, Justin H. Hwang, Vaia Florou, Ignacio Garrido‐Laguna, Emil Lou	3
6	Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers 2024 ·JCO Precision Oncology ·Thejus Jayakrishnan, Yasmine Baca, Joanne Xiu, M. Patel, Benjamin A. Weinberg, Emil Lou, Jashodeep Datta, Moh’d Khushman, Pat Gulhati, Sanjay Goel, Tiago Biachi De Castria, Vaia Florou, (unknown), Suneel Kamath, Alok A. Khorana	3
7	Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancer 2024 ·Cancer Gene Therapy ·Midhun Malla, Sachin Kumar Deshmukh, Sharon Wu, (unknown), (unknown), (unknown), Bassel F. El‐Rayes, Joanne Xiu, Alex Farrell, Heinz‐Josef Lenz, Emil Lou, Sanjay Goel, David Spetzler, Richard M. Goldberg, Lori Hazlehurst	6
8	Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma 2022 ·Cancer Control ·Ana Acuña-Villaorduña, V. Shankar, (unknown), (unknown), Rafi Kabarriti, (unknown), Inessa Goldman, Andreas Kaubisch, Santiago Aparo, Sanjay Goel, (unknown)	2
9	Increased Incidence of Thrombosis in a Cohort of Cancer Patients with COVID-19 2021 ·Acta Haematologica ·Phaedon D. Zavras, Vikas Mehta, Sanjay Goel, Kith Pradhan, Henny H. Billett	4
10	Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors 2020 ·Clinical Cancer Research ·Bonnie S. Glisson, Rom S. Leidner, Robert L. Ferris, John D. Powderly, Naiyer A. Rizvi, Bhumsuk Keam, Reva Schneider, Sanjay Goel, James Ohr, (unknown), Yanan Zheng, Steven Eck, Matthew Gribbin, Katie Streicher, Danielle M. Townsley, Sandip Pravin Patel	63
11	Elucidation of Pelareorep Pharmacodynamics in A Phase I Trial in Patients with KRAS -Mutated Colorectal Cancer 2020 ·Molecular Cancer Therapeutics ·Sanjay Goel, Allyson J. Ocean, (unknown), Mohammad H. Ghalib, Imran Chaudhary, Umang Shah, (unknown), (unknown), Matthew Coffey, Radhashree Maitra	25
12	A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma 2020 ·Clinical Cancer Research ·Sant P. Chawla, Sanjay Goel, Warren Chow, Fadi Braiteh, Arun S. Singh, Juneko E. Grilley‐Olson, Atsushi Osada, Iulian Bobe, Richard F. Riedel	29
13	Oncolytic Reovirus (pelareorep) Induces Autophagy in KRAS-mutated Colorectal Cancer 2020 ·Clinical Cancer Research ·(unknown), (unknown), Devika Rao, (unknown), (unknown), (unknown), (unknown), Imran Chaudhary, Titto Augustine, Sanjay Goel, Radhashree Maitra	37
14	Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System breakdown → 2020 ·Cancer Discovery ·Vikas Mehta, Sanjay Goel, Rafi Kabarriti, Daniel J. Cole, Mendel Goldfinger, Ana Acuña-Villaorduña, Kith Pradhan, Raja Thota, Stan Reissman, Joseph A. Sparano, Benjamin A. Gartrell, Richard V. Smith, Nitin Ohri, Madhur Garg, Andrew D. Racine, Shalom Kalnicki, Román Pérez-Soler, Balázs Halmos, Amit Verma	521
15	Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma Patients 2018 ·Canadian Journal of Gastroenterology and Hepatology ·Justin Tang, Nitin Ohri, Rafi Kabarriti, Santiago Aparo, (unknown), Sanjay Goel, Jonathan M. Schwartz, Milan Kinkhabwala, Andreas Kaubisch, Chandan Guha	3
16	Apoptotic Sensitivity of Colon Cancer Cells to Histone Deacetylase Inhibitors Is Mediated by an Sp1/Sp3-Activated Transcriptional Program Involving Immediate-Early Gene Induction 2010 ·Cancer Research ·Andrew J. Wilson, Anderly C. Chüeh, Lars Tögel, Georgia Corner, Naseem Ahmed, Sanjay Goel, Do-Sun Byun, Shannon Nasser, Michele Houston, Minaxi Jhawer, Helena J.M. Smartt, Lucas B. Murray, Courtney Nicholas, Barbara G. Heerdt, Diego Arango, Leonard H. Augenlicht, John M. Mariadason	96
17	An A13 Repeat within the 3′-Untranslated Region of Epidermal Growth Factor Receptor (EGFR) Is Frequently Mutated in Microsatellite Instability Colon Cancers and Is Associated with Increased EGFR Expression 2009 ·Cancer Research ·Ziqiang Yuan, Joongho Shin, Andrew J. Wilson, Sanjay Goel, Yi‐He Ling, Naseem Ahmed, Higinio Dopeso, Minaxi Jhawer, Shannon Nasser, Cristina Montagna, Kenneth Fordyce, Leonard H. Augenlicht, Lauri A. Aaltonen, Diego Arango, Thomas K. Weber, John M. Mariadason	32
18	A Phase I Study of Eribulin Mesylate (E7389), a Mechanistically Novel Inhibitor of Microtubule Dynamics, in Patients with Advanced Solid Malignancies 2009 ·Clinical Cancer Research ·Sanjay Goel, Alain C. Mita, Monica Mita, Eric K. Rowinsky, Quincy S. Chu, Nancy Wong, Christopher DesJardins, Fang Fang, Mendel Jansen, Dale E. Shuster, Sridhar Mani, Chris H. Takimoto	121
19	The Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamics of Ixabepilone: A First in Class Epothilone B Analogue in Late-Phase Clinical Development 2008 ·Clinical Cancer Research ·Sanjay Goel, Marvin L. Cohen, (unknown), Lionel Perrin, François André, David Jayabalan, Lisa Iacono, (unknown), (unknown), Donglu Zhang, Carrie Xu, (unknown), (unknown), Gary L. Goldberg, (unknown), Sridhar Mani	21
20	PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab 2008 ·Cancer Research ·Minaxi Jhawer, Sanjay Goel, Andrew J. Wilson, Cristina Montagna, Yi‐He Ling, Do-Sun Byun, Shannon Nasser, Diego Arango, Joongho Shin, Lidija Klampfer, Leonard H. Augenlicht, Roman Perez Soler, John M. Mariadason	370

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact